Literature DB >> 2723124

Pimobendan increases calcium sensitivity of skinned human papillary muscle fibers.

H H Scheld1, R Fritsche, M Schlepper, J C van Meel.   

Abstract

The calcium sensitizing effects of the cardiotonic agent pimobendan on force production were investigated on chemically skinned human papillary muscle fibres. The papillary muscles were obtained from patients undergoing mitral valve replacement operations. Tension was produced by different free calcium concentrations and 100 mumol/l of pimobendan shifted the pCa-tension relationship significantly to the left. The effects of pimobendan were concentration dependent (10-300 mumol/l) but additionally also correlated with the state of left ventricular performance of the patients. Skinned papillary muscle fibres obtained from patients with reduced ventricular performance were more sensitive to calcium as well as pimobendan compared with fibres from patients with normal left ventricular performance. No differences in response to pimobendan were observed between fibres from NYHA II and NYHA III heart failure patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723124     DOI: 10.1002/j.1552-4604.1989.tb03342.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  5 in total

1.  Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure.

Authors:  Miki Nonaka; Sachio Morimoto; Takashi Murayama; Nagomi Kurebayashi; Lei Li; Yuan-Yuan Wang; Masaki Arioka; Tatsuya Yoshihara; Fumi Takahashi-Yanaga; Toshiyuki Sasaguri
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

Review 2.  Inotropic agents for heart failure: what if digoxin increases mortality?

Authors:  W J Remme
Journal:  Br Heart J       Date:  1994-09

Review 3.  Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.

Authors:  A Fitton; R N Brogden
Journal:  Drugs Aging       Date:  1994-05       Impact factor: 3.923

4.  Low concentrations of UD-CG 212 enhance myocyte contractility by an increase in calcium responsiveness in the presence of inorganic phosphate.

Authors:  J C van Meel; N Redemann; W Diederen; R M Haigh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-06       Impact factor: 3.000

Review 5.  Functional and structural differences between skinned and intact muscle preparations.

Authors:  Alex Lewalle; Kenneth S Campbell; Stuart G Campbell; Gregory N Milburn; Steven A Niederer
Journal:  J Gen Physiol       Date:  2022-01-19       Impact factor: 4.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.